Published in Ter Arkh on January 01, 1978
Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol (1998) 0.96
Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol (2008) 0.92
Molecular pathogenesis of systemic lupus erythematosus. Arch Virol (1975) 0.85
Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol Lett (2002) 0.85
[Rosenthal's syndrome (hemophilia C) in a patient with psoriatic arthritis (a clinical case)]. Ter Arkh (1997) 0.85
DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases. FEBS Lett (1992) 0.83
Endocarditis with left atrial thrombus formation in Behçet's disease mimicking myxoma. J Rheumatol (1993) 0.82
[Cardiolipin antibodies in acute rheumatic fever]. Klin Med (Mosk) (1992) 0.82
[Aseptic necrosis of the temporomandibular joint in systemic lupus erythematosus]. Stomatologiia (Mosk) (1999) 0.81
[Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.81
[Role of obesity in the development of osteoarthrosis and concomitant diseases]. Ter Arkh (2010) 0.81
[Clinical-immunological disorders in uveitis in patients with Behçet's syndrome]. Vestn Oftalmol (1995) 0.79
[Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus]. Ter Arkh (1980) 0.79
[Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus]. Klin Med (Mosk) (2003) 0.78
[Synovial membrane in the early stage of rheumatoid arthritis: clinico-morphological comparisons]. Ter Arkh (2003) 0.78
[Clinical factors essential for dental caries intensity in rheumatic patients]. Stomatologiia (Mosk) (2002) 0.78
[Neutralisation of interferon gamma--a new trend in therapy of rheumatoid arthritis]. Ter Arkh (2008) 0.78
[Clinical significance of determining antibodies to poly A: poly U in systemic lupus erythematosus]. Ter Arkh (1972) 0.78
[The HLA-B5 immunogenetic marker in Behçet's disease]. Ter Arkh (1993) 0.78
[Characteristics of retinal vascular involvement in systemic lupus erythematosus]. Vestn Oftalmol (2001) 0.78
Cytogenetic adaptive response in cultured human lymphocytes: dependence on the time of exposure to adapting and challenging doses of gamma-rays. Mutat Res (1998) 0.78
[Catalytic autoantibodies--a new molecular instrument in cardiology and ophthalmology]. Ter Arkh (2006) 0.78
[Results of the multicenter clinical trial of structum preparation in Russia]. Ter Arkh (2001) 0.78
[Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases]. Vestn Oftalmol (2002) 0.77
[Behçet's disease: clinical and demographic associations]. Ter Arkh (2013) 0.77
[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77
[DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance]. Ter Arkh (2005) 0.76
[Soluble adhesion molecules (P-selectin, ICAM-1 and ICAM-3) in rheumatoid arthritis]. Ter Arkh (1999) 0.76
[Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Klin Med (Mosk) (1998) 0.76
[The role of estrogen-androgen imbalance in rheumatic diseases]. Ter Arkh (1990) 0.76
[Familial systemic scleroderma: a follow-up study of concordant monozygotic twins]. Ter Arkh (1981) 0.76
Endothelial inclusions and "nuclear bodies" in systemic lupus erythematosus. Ann Rheum Dis (1973) 0.75
[Isolation and characteristics of the DNA of donor and systemic lupus erythematosus patient blood plasma]. Biull Eksp Biol Med (1980) 0.75
[Diagnostic criteria of systemic lupus erythematosus]. Sov Med (1980) 0.75
[Regulatory cells of the immune system (helpers and suppressors) in NZB/W mice with autoimmune disorders]. Dokl Akad Nauk SSSR (1979) 0.75
Interactions of protein (antibodies) with the deoxyribonucleic acid molecule. Nature (1966) 0.75
[External respiration in patients with systemic lupus erythematosus]. Ter Arkh (1967) 0.75
[Research results in rheumatology during 1977]. Vopr Revm (1979) 0.75
[Some problems in the prevention of streptococcal infections]. Ter Arkh (1974) 0.75
[Remote results of corticosteroid therapy in systemic lupus erythematosus]. Ter Arkh (1979) 0.75
[Emergency situations in rheumatology]. Sov Med (1972) 0.75
[Determination of antibodies to DNA using radioimmunological methods and passive hemagglutination reaction in patients with systemic diseases of the connective tissue]. Sov Med (1976) 0.75
[Differentiated leukocyturia in lupus-nephritis]. Sov Med (1973) 0.75
[Immunological aspects of the study of rheumatoid arthritis]. Ter Arkh (1976) 0.75
[Collagen diseases and tuberculosis, their combinations and masks]. Probl Tuberk (1967) 0.75
[Treatment of rheumatoid arthritis with prolonged-action drugs]. Klin Med (Mosk) (1980) 0.75
[Antibodies to viral antigens in rheumatoid arthritis]. Sov Med (1976) 0.75
[Genetic aspects of rheumatic diseases]. Vestn Akad Med Nauk SSSR (1976) 0.75
[Cytogenetic study of patients with rheumatism in the process of aspirin therapy]. Ter Arkh (1972) 0.75
[Development of the field of "major" collagenoses (diffuse diseases of the connective tissue) in the USSR]. Vopr Revm (1970) 0.75
[Changes in otorhinolaryngological organs in systemic lupus erythematosus and systemic scleroderma]. Klin Med (Mosk) (1970) 0.75
[Current aspects of the viral etiology of systemic lupus erythematosus]. Vestn Akad Med Nauk SSSR (1975) 0.75
[Current data on the etiology of systemic lupus erythematosus]. Klin Med (Mosk) (1972) 0.75
[Characteristics of autoimmune disorder in systemic lupus erythematosus]. Ter Arkh (1974) 0.75
[Excretion of beta-aminoisobutyric acid in health, in systemic lupus erythematosus and leukemia]. Vopr Med Khim (1969) 0.75
[Clinical and pathogenetic patterns in chronic rheumatic inflammation]. Vestn Akad Med Nauk SSSR (1979) 0.75
[Controlled (double-blind) trial of levamisole in rheumatoid arthritis]. Ter Arkh (1980) 0.75
[Basic results of scientific study on the problem of rheumatism and joint diseases for 1970]. Vopr Revm (1972) 0.75
[Fulfillments of the problem-related plan concerning "Rheumatism and joint diseases" in 1974]. Vopr Revm (1976) 0.75
[Determination of antilymphocytic antibodies in systemic lupus erythematosus by indirect immunofluorescence technic using fixed lymphocytes]. Ter Arkh (1979) 0.75
[Plan for scientific research into the problem of rheumatology in 1979]. Vopr Revm (1979) 0.75
[Basic principles of differentiated therapy of patients with "major" collagenoses]. Vopr Revm (1970) 0.75
[Main results of carrying out the problem-oriented thematic plan of scientific research in rheumatology in 1971-1975]. Vopr Revm (1977) 0.75
[Clinico-immunological characteristics in Felty's syndrome]. Ter Arkh (1980) 0.75
[Characteristic and distribution of antibodies, interacting with single-strand DNA]. Vestn Akad Med Nauk SSSR (1967) 0.75
[Clinico-immuno-morphological characteristics of the early period of systemic lupus erythematosus]. Sov Med (1974) 0.75
[Anti-measles antibodies in systemic lupus erythematosus]. Sov Med (1972) 0.75
[Variant of collagenosis bordering infectious nonspecific (rheumatoid) polyarthritis and systemic lupus erythematosus]. Ter Arkh (1971) 0.75
[Antibodies to desoxyribonucleic acid (DNA) in diffuse connective tissue diseases]. Ter Arkh (1972) 0.75
[Aseptic bone necrosis in systemic lupus erythematosus and related diseases]. Ter Arkh (1980) 0.75
[Problems of prophylactic examination of patients with rheumatic diseases]. Ter Arkh (1977) 0.75
[Basic problems of the early diagnosis and nosology of connective tissue diseases]. Vopr Revm (1972) 0.75
[Main results of the research in rheumatology during 1978]. Vopr Revm (1980) 0.75
[Ultrastructural data on the immune-complex nature of vascular lesions in systemic lupus erythematosus]. Ter Arkh (1980) 0.75
[Clinico-pathogenetical characteristics of rheumocarditis with minimal activity]. Kardiologiia (1975) 0.75
[Human lymphocyte chromosome reaction to single and fractionated gamma irradiation at different stages of the mitotic cycle]. Radiobiologiia (1980) 0.75
[Catabolic enzymes of the connective tissue in clinical aspects and pathogenesis of lupus-nephritis]. Sov Med (1974) 0.75
[Scientific and organizational problems in the development of rheumatology]. Sov Zdravookhr (1980) 0.75
[Clinical variants in the course and activity of lupus nephritis]. Ter Arkh (1971) 0.75
[Problems in the treatment of joing diseases (according to data of the 4th Congress of Rheumatologists GDR, Weimar, September 11-13, 1974)]. Ter Arkh (1975) 0.75
[Clinical importance of determination of acid phosphatases and cathepsins in the urine of patients with systemic lupus erythematosus]. Ter Arkh (1977) 0.75
[Atypical form of rheumatoid arthritis bordering systemic lupus erythematosus]. Ter Arkh (1974) 0.75
[Plan for research on the problem of rheumatology in 1980]. Vopr Revm (1980) 0.75
[Virological study of the blood in systemic lupus erythematosus]. Vopr Virusol (1975) 0.75
[Use of I125 labelled poly(I). poly(C) for determination of antibodies to double-stranded RNA by immune complex absorption to nitrocellulose filters]. Mol Biol (Mosk) (1976) 0.75
[Digestive organs and systemic connective tissue diseases]. Klin Med (Mosk) (1979) 0.75
[Urgent problems of modern rheumatology]. Ter Arkh (1975) 0.75
[Serum proteins reacting with DNA and DNA-RNA hybrids in New Zealand mice of different ages]. Dokl Akad Nauk SSSR (1980) 0.75
[New data on the etiology and pathogenesis of rheumatism]. Ter Arkh (1976) 0.75
[Basic results of the study of rheumatism]. Vopr Revm (1979) 0.75
[Clinical and pathogenetic characteristics of acute and protracted rheumatism]. Klin Med (Mosk) (1980) 0.75
[Main results and perspectives of the development of Cardio-Rheumatological service]. Ter Arkh (1974) 0.75
[Results of long-term observations of systemic lupus erythematosus patients]. Ter Arkh (1968) 0.75
[The 3d component of complement (B1A globulin) in collagenoses and its diagnostic significance]. Ter Arkh (1974) 0.75